Triggr Health
Medication-Assisted Treatment (MAT)
Medication-assisted treatment (MAT) combines FDA-approved medications with counseling and behavioral therapy to treat opioid or alcohol use disorder — considered an evidence-based standard of care, particularly for opioid use disorder.
Need help with addiction? Call our 24/7 Helpline now to speak with an Addiction Expert.
(844) 569-1713How MAT Works
The medications used in MAT work by reducing cravings and withdrawal symptoms, and in some cases by blocking the effects of the substance entirely. That reduction is what makes the behavioral and psychological work of recovery more accessible: it's difficult to engage meaningfully in therapy while in the grip of intense cravings or withdrawal. Medication stabilizes the physiology; counseling addresses the patterns and causes. Neither half is the whole treatment.
The Medications, Substance by Substance
| Medication | Used for | How it works, briefly |
|---|---|---|
| Methadone | Opioid use disorder | A long-acting opioid agonist that prevents withdrawal and reduces cravings at supervised, stable doses; dispensed through certified opioid treatment programs. |
| Buprenorphine (incl. Suboxone) | Opioid use disorder | A partial agonist that controls cravings and withdrawal with a ceiling on opioid effects; can be prescribed in office-based settings, making it the most accessible OUD medication. |
| Naltrexone (oral or monthly injection) | Opioid and alcohol use disorder | An antagonist that blocks opioid effects and reduces alcohol cravings; requires full opioid withdrawal before starting. |
| Acamprosate | Alcohol use disorder | Helps stabilize brain chemistry after drinking stops, supporting sustained abstinence. |
| Disulfiram | Alcohol use disorder | Creates an acute unpleasant reaction if alcohol is consumed — a deterrent that works for some people as part of a broader plan. |
Which medication fits is a genuinely individual clinical decision — shaped by the substance involved, treatment history, health picture, and practical access — made with a prescriber, not from a table.
A Common Misconception
MAT is sometimes mischaracterized as "replacing one drug with another." It isn't — the medications are administered at medically supervised doses specifically to stabilize brain chemistry and reduce harm, not to produce the same effects as the substance being treated. Major medical and public health bodies — including SAMHSA, the FDA, and the major addiction medicine societies — recognize MAT as evidence-based treatment, and for opioid use disorder specifically, medication is associated with staying in treatment longer and substantially reduced overdose risk. The stigma around it has cost lives; the evidence base is not ambiguous.
How Long People Stay on MAT
This varies significantly by individual. Some people use MAT for a period of months during early recovery and taper off under medical supervision; others continue longer-term, sometimes indefinitely, much like ongoing medication for any chronic condition. Neither approach is inherently right or wrong — it depends on the person's circumstances and response to treatment, and the decision to taper should be made with the prescriber rather than unilaterally, since discontinuing opioid-use-disorder medication abruptly carries real relapse and overdose risk.
MAT Combined With Other Treatment
MAT is rarely used in isolation. Most programs combine it with counseling — whether that's outpatient therapy, IOP, or a fuller residential program — since medication addresses physical dependence while counseling addresses the behavioral patterns and underlying causes of substance use. For opioid withdrawal specifically, medication often starts during medical detox and simply continues as ongoing treatment afterward, which is one of the cleaner handoffs in the whole continuum.
Access and Coverage
Access has improved meaningfully in recent years — buprenorphine can now be prescribed by most practitioners with a standard DEA registration, and telehealth prescribing has widened reach further. Methadone remains dispensed through certified opioid treatment programs. Most private insurance plans, Medicaid, and Medicare cover MAT medications and the accompanying counseling, though plan-specific rules (prior authorization for certain formulations, preferred pharmacies) apply — see our insurance guide for how to verify specifics.
Browse Medication-Assisted Treatment (MAT) by State
Frequently Asked Questions
Is MAT just trading one addiction for another?
No. MAT medications are taken at stable, medically supervised doses that normalize brain function rather than producing a high, and the evidence links them — for opioid use disorder especially — to longer treatment retention and substantially lower overdose risk. Every major medical body treats MAT as evidence-based care.
How long do I have to stay on MAT?
There's no universal answer. Some people taper after months; others stay on medication long-term the way people do for other chronic conditions. What matters is that any taper happens deliberately, with the prescriber, because abrupt discontinuation carries real relapse and overdose risk.
Do I have to do counseling to get MAT?
Best practice combines medication with counseling, and most programs are built that way, since the two address different halves of the disorder. Access rules have loosened so that medication isn't held hostage to counseling availability, but treating MAT as medication-only leaves a lot of its value unused.
What's the difference between methadone and Suboxone?
Methadone is a full opioid agonist dispensed through certified treatment programs, typically with daily visits early on. Buprenorphine (the active medication in Suboxone) is a partial agonist with a built-in ceiling effect that can be prescribed in regular office and telehealth settings. Which fits better is an individual clinical and practical decision.
Is MAT covered by insurance?
Most private plans, Medicaid, and Medicare cover MAT medications and associated counseling. Specific formulations sometimes require prior authorization, so it's worth having the prescriber or facility verify the details for your plan.